Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II-IIIA NSCLC patients

MLA

Vessies, D. C. L., et al. “Combining Variant Detection and Fragment Length Analysis Improves Detection of Minimal Residual Disease in Postsurgery Circulating Tumour DNA of Stage II-IIIA NSCLC Patients.” Molecular Oncology, 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366740149&authtype=sso&custid=ns315887.

APA

Vessies, D. C. L., Schuurbiers, M. M. F., Noort, V. van den, Schouten, I., Linders, T. C., Lanfermeijer, M., Ramkisoensing, K. L., Hartemink, K. J., Monkhorst, K., Heuvel, M. M. van den, & Broek, D. van den. (2022). Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II-IIIA NSCLC patients. Molecular Oncology.

Chicago

Vessies, D.C.L., M.M.F. Schuurbiers, V. van den Noort, I. Schouten, T.C. Linders, M. Lanfermeijer, K.L. Ramkisoensing, et al. 2022. “Combining Variant Detection and Fragment Length Analysis Improves Detection of Minimal Residual Disease in Postsurgery Circulating Tumour DNA of Stage II-IIIA NSCLC Patients.” Molecular Oncology. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366740149&authtype=sso&custid=ns315887.